However, ephrinB2–EphB4 signaling is complex: it can lead to tumor progression and tumor arrest/reduction, depending on the cancer entity, ligand expression, receptor expression, internalization status, forward–reverse signaling balance, the microenvironment the tumor grows in and many other unidentified aspects. This evidence concerns the gene EFNB2 and cancer.